China Universal Asset Management Company’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Buy |
9,889
+107
| +1% | +$11.2K | 0.1% | 162 |
|
|
2025
Q1 | $1.14M | Sell |
9,782
-494
| -5% | -$57.6K | 0.11% | 170 |
|
|
2024
Q4 | $869K | Buy |
10,276
+1,044
| +11% | +$88.3K | 0.08% | 177 |
|
|
2024
Q3 | $830K | Buy |
9,232
+3,652
| +65% | +$328K | 0.09% | 155 |
|
|
2024
Q2 | $449K | Sell |
5,580
-3,523
| -39% | -$284K | 0.06% | 155 |
|
|
2024
Q1 | $726K | Buy |
9,103
+3,628
| +66% | +$290K | 0.09% | 148 |
|
|
2023
Q4 | $436K | Buy |
5,475
+4,271
| +355% | +$340K | 0.08% | 152 |
|
|
2023
Q3 | $84.1K | Buy |
1,204
+633
| +111% | +$44.2K | 0.02% | 206 |
|
|
2023
Q2 | $41K | Sell |
571
-18
| -3% | -$1.29K | 0.01% | 209 |
|
|
2023
Q1 | $36.3K | Buy |
589
+148
| +34% | +$9.13K | 0.01% | 176 |
|
|
2022
Q4 | $34K | Buy |
441
+64
| +17% | +$4.94K | 0.01% | 150 |
|
|
2022
Q3 | $17K | Buy |
+377
| New | +$17K | 0.01% | 163 |
|